Posted On: 04/01/2015 12:51:06 PM
Post# of 30079
Re: All Aboard #19001
Assuming what the JV jet setting CEO tweeted is true, the extra money they are paying is helping to get ESS ready to start clinical trials instead of AMBS doing it. My guess is that it would cost AMBS much more to do the work that Lonza is doing for them. WE'll see.
(0)
(0)
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.
